New Trials in Prostate Cancer: Could Your Patient Benefit?
Several new clinical trials in prostate cancer have opened in recent months. Maybe one of your patients is eligible to participate? Prostate cancer at high risk for biochemical recurrence following radical prostatectomy and/or radiation therapy. Adult patients with this diagnosis can join a randomized, double-blind, placebo-controlled phase 3 study evaluating darolutamide (Nubeqa) plus androgen deprivation therapy (ADT) against ADT alone. […]
Continue reading »